To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what (a) type and (b) make of covid-19 vaccines the UK is donating to (a) COVAX and (b) bilateral arrangements with low and middle-income countries as of 28 March 2022.
31 March 2022
As a force for good in the world, through our participation in COVAX and by sharing vaccines, the UK is championing the need for access for all countries. As of 28 March the UK has delivered Adenovirus (AstraZeneca and Janssen/Johnson and Johnson) vaccines to low and middle-income countries through COVAX, who will also soon be delivering UK Protein Adjuvant (Novavax) vaccines to developing countries in line with their fair allocation model. We also have made bilateral donations, and are working on bilateral deliveries of AstraZeneca and mRNA (Moderna and Pfizer) vaccines in the coming months.
The UK was one of the earliest and largest donors to COVAX, contributing £548 million to the COVAX Advance Market Commitment (AMC). Our early funding gave the COVAX AMC the purchase power to secure deals with manufacturers to supply internationally approved vaccines for up to 92 low and middle-income countries. So far, COVAX has helped deliver over 1.16 billion doses to 144 participants.